drugset / Trial / NCT00695864

Effect of Ondansetron for Withdrawal Symptoms

NCT00695864

Completed 31 enrolled Stanford University
Non-randomizedSingle-groupDouble-blindTreatment

Summary

We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has shown anecdotal evidence of being affective for the treatment of withdrawal symptoms and we hope to determine whether this is affective.

Timeline

Start
2008-05
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified